OS Therapies Inc’s (NYSE:OSTX) Quiet Period Will Expire on September 10th

OS Therapies’ (NYSE:OSTX) quiet period will expire on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its IPO on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During the company’s quiet period, insiders and underwriters involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Analyst Ratings Changes

Several analysts have recently weighed in on OSTX shares. EF Hutton Acquisition Co. I upgraded shares of OS Therapies to a “strong-buy” rating in a research note on Tuesday. Brookline Capital Management raised shares of OS Therapies to a “strong-buy” rating in a research note on Thursday, August 22nd.

OS Therapies Stock Up 4.5 %

Shares of OS Therapies stock opened at $4.18 on Friday. OS Therapies has a 52 week low of $2.51 and a 52 week high of $4.90.

OS Therapies (NYSE:OSTX) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.26) earnings per share (EPS) for the quarter. Sell-side analysts predict that OS Therapies will post -0.47 EPS for the current fiscal year.

About OS Therapies

OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.